18525612. Active Agent Delivery Devices and Methods of Using the same simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
Contents
- 1 Active Agent Delivery Devices and Methods of Using the same
- 1.1 Organization Name
- 1.2 Inventor(s)
- 1.3 Active Agent Delivery Devices and Methods of Using the same - A simplified explanation of the abstract
- 1.4 Simplified Explanation
- 1.5 Potential Applications
- 1.6 Problems Solved
- 1.7 Benefits
- 1.8 Potential Commercial Applications
- 1.9 Possible Prior Art
- 1.10 Unanswered Questions
- 1.11 Original Abstract Submitted
Active Agent Delivery Devices and Methods of Using the same
Organization Name
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Inventor(s)
Kiana Aran of Berkeley CA (US)
Jacobo Paredes of Berkeley CA (US)
Niren Murthy of Berkeley CA (US)
Dorian Liepmann of Lafayette CA (US)
Active Agent Delivery Devices and Methods of Using the same - A simplified explanation of the abstract
This abstract first appeared for US patent application 18525612 titled 'Active Agent Delivery Devices and Methods of Using the same
Simplified Explanation
The patent application describes active agent delivery devices designed to deliver active agent formulations into or through a mucosal layer in a subject. These devices include a power reservoir that can eject the active agent formulation at a pressure high enough to penetrate the mucosal layer. Methods of using these devices are also included in the patent application.
- The active agent delivery devices are configured to deliver active agent formulations into or through a mucosal layer in a subject.
- The devices include a power reservoir that can eject the active agent formulation at a pressure sufficient to penetrate the mucosal layer.
- Methods of using the active agent delivery devices are provided in the patent application.
Potential Applications
The technology could be used in medical applications for targeted drug delivery through mucosal layers, potentially improving the effectiveness of treatments.
Problems Solved
The technology addresses the challenge of delivering active agents through mucosal layers, which can be a barrier to effective treatment in some cases.
Benefits
- Enhanced targeted delivery of active agents - Improved effectiveness of treatments - Potential for reduced side effects compared to systemic delivery methods
Potential Commercial Applications
The technology could have commercial applications in pharmaceuticals, medical devices, and drug delivery systems.
Possible Prior Art
Prior art in this field may include existing drug delivery devices designed for mucosal administration, such as nasal sprays or buccal patches.
Unanswered Questions
How does the technology compare to existing mucosal delivery devices in terms of efficacy and safety?
The article does not provide a direct comparison between this technology and existing mucosal delivery devices.
Are there any limitations or potential drawbacks to using these active agent delivery devices?
The article does not address any limitations or potential drawbacks associated with the use of these devices.
Original Abstract Submitted
Provided are active agent delivery devices configured to deliver an active agent formulation into or through a mucosal layer in a subject. The active agent delivery devices include a power reservoir configured to eject the active agent formulation at a pressure sufficient to deliver the active agent formulation into or through a mucosal layer in a subject. Methods of using the subject active agent delivery devices are also provided.
